Close

SNSS Financial Facts

Loss from operations: -9.99M
Research and development: 6.61M
See Full Income Statement

Total current assets: 33.95M
Prepaids and other current assets: 831K
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +18.6% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -39.1% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/8/12 Q312 -$0.37-$0.13 -$0.24$265K$4.17M N/A Details
3/29/11 Q410 -$0.23-$0.10 -$0.13N/AN/A N/A Details
5/15/12 Q112 -$0.30-$0.18 -$0.12N/A$90K N/A Details
5/7/14 Q114 -$0.26-$0.17 -$0.09$2M$1.32M N/A Details
11/10/14 Q314 -$0.25-$0.17 -$0.08$854K$1.97M N/A Details
8/11/11 Q211 -$0.18-$0.15 -$0.03N/A$10K N/A Details
5/9/13 Q113 -$0.23-$0.20 -$0.03$1.99M$750K N/A Details
8/5/14 Q214 -$0.20-$0.17 -$0.03$2M$1.32M N/A Details